•
Dec 31, 2020

Verve Therapeutics Q4 2020 Earnings Report

EPS
-$20.3
Cash and Equivalents
$8.99M
Free Cash Flow
-$15.9M
Total Assets
$78.4M

Verve Therapeutics

Verve Therapeutics